Navigation Links
Aposense Receives Frost & Sullivan Technology Innovation of the Year Award
Date:11/6/2008

at the cellular level."

Aposense's imaging technology can thus provide real-time answers to important qualitative and quantitative questions, while allowing physicians to make better use of their therapeutic arsenal. Aposense(R) technology could also play an important role in bio-guided radiotherapy, where Aposense will enable adjusting the radiation field and dose to optimise its effectiveness.

"Some additional significant advantages of Aposense's technology for medical imaging are its long shelf life and in vivo stability, its low required dose, and its rapid clearance from non-target tissues through the urine," adds Austin. "Moreover, the technology is clinically-compatible, and its implementation does not require any changes in current standard medical imaging equipment or methods."

While there are a few other probes for cell death in vitro in cell culture, Aposense(R) ML-10 is the only agent currently available for the clinical detection of 'cell death in the living body'. Limitations of other investigated probes include toxicity, chemical reactivity, and immunogenicity. Furthermore, these probes have problems of bio-distribution and rapid metabolism and degradation in vivo, which consequently lead to low signal/background ratios.

"Low-molecular weight compounds are advantageous over large protein products on the market in many aspects, such as immunogenicity, metabolism, radiolabeling or bio-distribution," comments Austin. "Therefore, Aposense has utilized a nanotechnology approach in designing a molecule with minimised structure, which maintains biological performance in the detection of apoptotic cells; the company's lead product for molecular imaging, the Aposense (18F)- ML-10 for PET imaging, has a molecular weight of only 206."

Frost & Sullivan's Technology Innovation Award is bestowed upon a company (or individual) that has carried out new research, which has resulted in innovation(s) that have or are expected to bring
'/>"/>

SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
5. IsoTis Receives FDA Clearance for Accell Family of Products
6. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
7. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
8. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
9. XTL Receives Staff Letter From NASDAQ
10. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
11. Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Iowa, Dec. 4 Vivakor, Inc. (OTC Bulletin Board: ... December 1, 2009 will receive the dividend of shares ... approved by Vivakor,s Board of Directors. HealthAmerica is ... 84% of the outstanding common shares on the record ...
(Date:12/4/2009)... IRVINE, Calif., Dec. 4 BlueFire Ethanol Fuels, Inc. (OTC ... transportation fuel paradigm through the production of ethanol from non-food ... Biofuels Digest list of the "50 Hottest Companies in ... ,, "Having voters rank BlueFire Ethanol among the top ...
(Date:12/3/2009)... ACCESS PHARMACEUTICALS, INC. ... its European commercial launch of MuGard, an FDA approved ... radiation treatment and chemotherapy. MuGard is commercially launched by ... UK, Germany, Italy, Norway, Greece and Sweden. Access is ...
(Date:12/3/2009)... Inc. (Nasdaq: PPHM ) today announced that it will ... year 2010 on December 10, 2009 at 7:00 a.m. EST ... the results at 11:30 a.m. EST on the same day. ... second quarter ended October 31, 2009 and will review recent ...
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2
... Angel and venture investors have fewer secrets these days, ... advice to early-stage executives during the National SBIR-STTR Conference. ... ties to the University of Wisconsin-Madison , they ... have a sustainable market advantage, and what each round ...
... HR executives were getting used to having a brisk wind behind ... and economic winds reverse - blowing back against them and at ... press and reports issued by various associations, think tanks, and consulting ... the recruiting machine because 'talent' will soon be (if it isn't ...
... - Merge Healthcare (Nasdaq: MRGE), a financially embattled ... million, or 32 cents per share, during the third quarter ... executives resign and faced delisting from the NASDAQ Stock ... net loss for the first nine months of 2006 of ...
Other Biology Technology:Early-stage executives hear from investors 2Early-stage executives hear from investors 3The misguided talent war 2The misguided talent war 3The misguided talent war 4The misguided talent war 5
(Date:12/3/2009)... 30-year record low in Antarctic snowmelt that occurred during ... strong positive phases for two main climate drivers, ENSO ... Annular Mode), according to Dr. Marco Tedesco, Assistant Professor ... of New York. , Professor Tedesco, who ...
(Date:12/2/2009)... and alcohol consumption before head and neck cancer diagnosis ... to published studies. Now, results of a new study ... habits after cancer diagnosis. , "Most cancer survivors are ... In our study, 21 percent continued to smoke even ...
(Date:12/2/2009)... cancer-free status did not prompt people participating in ... to pick up their cigarettes again, researchers wrote ... Biomarkers & Prevention , a journal of the ... contains a special focus on tobacco. , These ...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2STAAR Surgical Receives FDA Clearance for the Epiphany 28TM 29 Injector System 12581 1STAAR Surgical Receives FDA Clearance for the Epiphany 28TM 29 Injector System 12581 2STAAR Surgical Receives FDA Clearance for the Epiphany 28TM 29 Injector System 12581 3Soyfoods a Healthy Choice for Men 48575 1Soyfoods a Healthy Choice for Men 48575 2Soyfoods a Healthy Choice for Men 48575 3Soyfoods a Healthy Choice for Men 48575 4The Hidden Story 3A Poetry Inspired by Authors Struggle with Depression Addiction 48573 1The Hidden Story 3A Poetry Inspired by Authors Struggle with Depression Addiction 48573 2
... EMEA spurs IdentiPHI,s company ... expansion, ... solutions and services, announces its,expansion with the opening of an office in ... authentication (access,management) products and solutions., "Opening the office in Europe will ...
... 2007- Antibiotic resistance is a growing human health ... and other pharmaceuticals to be present in surface ... and underlying groundwater. In a recent article in ... researchers at Colorado State University (CSU) describe a ...
... for decades, but surprisingly, little is known about how ... groundbreaking study published November 28 in the advance online ... the first time measured which of the parasite,s genes ... humans, not in cell cultures, unearthing surprising behaviors and ...
Other Biology News:IdentiPHI Opens Paris Office to Boost European Sales and Support 2Manure management reduces levels of antibiotics and antibiotic resistance genes 2Study of malaria parasite in patient blood finds distinct physiological states 2Study of malaria parasite in patient blood finds distinct physiological states 3Study of malaria parasite in patient blood finds distinct physiological states 4
... The IITC Model 20-NW cuff pump is ... blood pressure testing. This cuff pump replaces manual ... indirect blood pressure test systems for mouse and ... available. The IITC Model 20-NW cuff pump has ...
... are specifically depleted of a single complement ... protein, the alternative and classical pathways are ... for the detection and quantitation of hemolytically ... used to assess complement activation in non-human ...
... by luciferase-cDNA transfected cell lines has proven ... development of reporter gene assays in which ... for the transcription of other genes. The ... to advantages such as high sensitivity and ...
... used to reveal two distinct antigens in ... a Zymed polymer double staining detection method ... same human cell or tissue sample with ... using two different primary antibodies from mouse ...
Biology Products: